Increase in gastric pH reduces hypotensive effect of oral sodium nitrite in rats
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
01/11/2013
01/11/2013
2012
|
Resumo |
The new pathway nitrate-nitrite-nitric oxide (NO) has emerged as a physiological alternative to the classical enzymatic pathway for NO formation from L-arginine. Nitrate is converted to nitrite by commensal bacteria in the oral cavity and the nitrite formed is then swallowed and reduced to NO under the acidic conditions of the stomach. In this study, we tested the hypothesis that increases in gastric pH caused by omeprazole could decrease the hypotensive effect of oral sodium nitrite. We assessed the effects of omeprazole treatment on the acute hypotensive effects produced by sodium nitrite in normotensive and L-NAME-hypertensive free-moving rats. In addition, we assessed the changes in gastric pH and plasma levels of nitrite, NOx (nitrate+ nitrite), and S-nitrosothiols caused by treatments. We found that the increases in gastric pH induced by omeprazole significantly reduced the hypotensive effects of sodium nitrite in both normotensive and L-NAME-hypertensive rats. This effect of omeprazole was associated with no significant differences in plasma nitrite, NOx, or S-nitrosothiol levels. Our results suggest that part of the hypotensive effects of oral sodium nitrite may be due to its conversion to NO in the acidified environment of the stomach. The increase in gastric pH induced by treatment with omeprazole blunts part of the beneficial cardiovascular effects of dietary nitrate and nitrite. (c) 2012 Elsevier Inc. All rights reserved. Fundacao de Aparo a Pesquisa do Estado de Sao Paulo Fundacao de Aparo a Pesquisa do Estado de Sao Paulo Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior |
Identificador |
FREE RADICAL BIOLOGY AND MEDICINE, NEW YORK, v. 53, n. 4, supl. 6, Part 1, pp. 701-709, AUG 15, 2012 0891-5849 http://www.producao.usp.br/handle/BDPI/37698 10.1016/j.freeradbiomed.2012.06.001 |
Idioma(s) |
eng |
Publicador |
ELSEVIER SCIENCE INC NEW YORK |
Relação |
FREE RADICAL BIOLOGY AND MEDICINE |
Direitos |
closedAccess Copyright ELSEVIER SCIENCE INC |
Palavras-Chave | #NITRITE #OMEPRAZOLE #HYPERTENSION #L-NAME #FREE RADICALS #NO IN-VIVO #DIETARY NITRATE #BLOOD-PRESSURE #RENOVASCULAR HYPERTENSION #OXIDE METABOLITES #REDUCTION #HUMANS #BIOLOGY #DEOXYMYOGLOBIN #THERAPEUTICS #BIOCHEMISTRY & MOLECULAR BIOLOGY #ENDOCRINOLOGY & METABOLISM |
Tipo |
article original article publishedVersion |